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Abstract 
This study examined the impact of overweight/obese on the sodium, potassium and blood pressure associations using SMASH project 
baseline survey data. 24-h urine samples were collected in 1948 Chinese adults aged 18-69 years.The observed associations of sodium, 
potassium, sodium-potassium ratio and systolic blood pressure (SBP) were stronger in the overweight/obese population than among those of 
normal weight. Among overweight/obese respondents, each additional standard deviation (SD) higher of urinary sodium excretion 
(SD=85mmol) and potassium excretion (SD=19mmol) was associated with 1.31mmHg (95%CI, 0.37,2.26) and -1.43mmHg (95%CI, 
-2.23,-0.63) difference in SBP, each higher unit in sodium-potassium ratio was associated with 0.54mmHg (95%CI, 0.34, 0.75) increase in 
SBP. The association between sodium, potassium, sodium-potassium ratio and prevalence of hypertension among the overweight/obese was 
similar to that of SBP. Our study indicated that the relationships between BP and both urinary sodium and potassium might be modified by 
BMI status in Chinese adults.  
 
Keywords: sodium, potassium, blood pressure, body mass index  
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Abbreviations 
BMI ─body mass index 
BP ─blood pressure 
CVD ─ cardiovascular disease 
DBP ─diastolic blood pressure 
IOM ─Institute of Medicine 
OR ─odds ratio 
Q ─quintile 
SBP ─systolic blood pressure 
SD ─standard deviation 
SE ─standard error 
SMASH ─Shandong and Ministry of Health Action on Salt and Hypertension  
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Introduction 
Cardiovascular disease (CVD), including heart disease and stroke, accounted for 41% of all deaths and 23% of national health care 
spending in China in 2005(1). Unfortunately, the prevalence of hypertension, the leading risk factor for CVD, has increased dramatically 
in China, from 5.1% in 1959 to 29.6% in 2009 among adults aged 18 years and older(2,3). High sodium intake, low potassium intake, 
and obesity all increase the risk of hypertension(4,5,6). In China, sodium intake decreased over the last 2 decades, but studies 
suggested that average daily intake in 2009 (4700 mg/d) was almost double the Chinese Nutrition Association recommendation 
(2400mg/d)(7). The average daily potassium intake among Chinese adults is very low, resulting in a high sodium-potassium ratio, 
indeed one of the highest in the world (5,7,8).In addition, overweight and obesity have increased remarkably in China over the past two 
decades; in 2010, 30.6% of Chinese adults were overweight, and 12% were obese(9,10). 
 
The U.S. Institute of Medicine (IOM) recommended that analyses on the effects of dietary sodium on health outcomes should also 
examine potassium intake and account for potential confounding factors(11). In addition, accumulating evidence has suggested that in 
humans the response of blood pressure (BP) to changes in sodium intake may vary by body weight/BMI or the presence of the 
metabolic syndrome(12-16). In China, several population-based studies have linked sodium and potassium intake and their ratio with 
blood pressure and risk of hypertension(17-19). However, few studies have examined the relationship between sodium and potassium 
intake and BP in analyses stratified by BMI status(20,21). The INTERSALT study examined the Chinese subsample to assess the 
effect modification of BMI on the association of sodium and BP(20). However, the sample was relatively small and was based on just 
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3 Chinese neighborhoods. In addition, the sample was collected 20-30 years ago, when the prevalence of hypertension and obesity in 
China were relatively low. Therefore, we sought to understand how the association of sodium and BP might be modified by BMI status 
among Chinese adults in the contemporary setting. 
 
We used baseline survey data from2011 obtained as part of the Shandong and Ministry of Health Action on Salt and Hypertension 
(SMASH) project to examine the association between 1) urinary sodium, urinary potassium, and their ratioand2) BP and the prevalence 
of hypertension. We also explored whether the associationsof sodium and potassium with BP and hypertension prevalence are modified 
byBMI. 
 
Methods 
Study population 
The SMASH project survey was a representative cross-sectional survey of adults aged 18 to 69 years in Shandong Province, which in 2010 
had 96 million residents. Using a complex, multi-stratified cluster sampling method, we selected 2112 participants for a timed 24-h urine 
collection from 20 counties/districts across Shandong province. A detailed description of the study design and methods for the SMASH 
project survey is available elsewhere(22). Our study was conducted according to Declaration of Helsinki guidelines, and all procedures 
involving human subjects were approved by the ethics committee of the Shandong Center for Disease Control and Prevention. Participants 
provided written informed consent.  
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24-hour urine collection 
We used the INTERSALT method to perform the 24-h urine collection(23). Each participant was instructed on this process by atrained 
health professional at the collection field sites. The participant was given a standard plastic container with boric acid (around 1 g) used as 
preservative and was told to discard the first void of the day and collect all the urine in the container during the following 24-h period 
including the first void from the next morning. The health professional recorded the beginning and ending time for each urine collectionand 
the total hours between the first and last void collected. A standard interview by questionnairewas administered to each participant at the end 
of the 24-h period to assess the completeness of urine collection. The volume of urine was measured on a standard platform at the field site 
by a laboratory technician. The samples were kept in a freezer at -20
o
C and delivered to the certified laboratory (ADICON Clinical 
Laboratory Inc.) in Jinan, Shandong.Urinary sodium and potassium were measured by the ion-selective electrode method on an Olympus 
AU 680 Chemistry-Immuno Analyzer; the coefficient of variation was 1.5% for sodium and 2.5% for potassium.Urinary creatinine was 
measured by the picric acid method using the Olympus AU640 Chemistry-Immuno Analyzer (here the coefficient of variation was 3.0%). 
Individual sodium and potassium excretion values were calculated from their concentration in the 24-h sample. 
 
Anthropometric and blood pressure data 
Weight, height, and BP were measured by trained health professionals using standardized methods(22). According to the Chinese guidelines 
for overweight and obesity(24), normal weight is defined as a BMI(kg/m2) of ≥18.5 to <24, while overweightis defined as a BMI of 24 to 
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<28. Those with a BMI≥28 are considered obese.We combined overweight or obese participants in a single group (overweight/obese) to 
produce more stable estimates.  
 
BP was measured in the sitting position 3 times 5 min apart on one occasion by trained health professionals with electronic 
sphygmomanometer (HEM-7071, Omron Corporation). The average of the 3 measurements was used. Hypertension was defined by the 
Chinese guidelines on preventing and controlling hypertension and the JNC 7 as asystolic BP (SBP)≥140mmHg or a diastolic BP (DBP)≥90 
mmHg, or a self-report of taking antihypertensive medication(s) in the last 2 wk(25,26). 
 
Data analysis 
An incomplete urine collection was defined as either a 24-h urinary volume less than 500ml, or a 24-h urinary creatinine volume beyond the 
sex-specific mean±2standard deviations (SD).We identified 88 participants with incomplete 24-h urine collection and excluded them from 
our analytic sample.An additional 76 participants who were underweight (BMI<18.5) were also excluded, leaving a total of 1948 adults for 
the data analysis. 
 
The covariates in this analysis included age, sex, educational attainment, smoking status, frequency of drinking alcohol, physical activity, 
and use of antihypertensive medication(s). Data on these variables were collected by in-person interview using a standardized questionnaire. 
Frequency of drinking alcohol was categorized in 4 groups: nondrinker, <1 d/wk, 1-2d/wk,or≥3d/wk. Physical activity was defined by the 
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frequency of leisure-time exercise: none, <3 d/wk, or ≥3 d/wk. Tobacco smoking status was categorized as none, former smoker, or current 
smoker. The missing values were coded as a missing group within the covariates. Ninety participants had missing values for covariates: 18 
for smoking, 14 for physical activity, and 60 for drinking (2 participants had 2 missing values, and 88 had 1 missing value). 
 
Statistical analysis 
We calculated the weighted mean and standard error (SE) of the 24-h urinary sodium output, potassium output, and the sodium-potassium 
ratio, by the selected covariates and BMI. The sample weights were determined by the design weight and a post-stratification weight 
adjustment to correct for oversampling or under sampling(22,27). The Wald-F test was used to assess the differences across the categories of 
the covariates. We used multivariable linear regression to examine the associations of urinary sodium output, potassium output, and the 
sodium-potassium ratio with SBP and DBP. We estimated the adjusted β-coefficients associated with having a 1-SD-higher urinary sodium 
(SD=85mmol), a 1-SD-higher potassium (SD=19mmol), and a 1-unit difference in the sodium-potassium ratio among all adultsand by 
BMIstatus. 
 
The dose-response relationship between urinary sodium excretion and BP while adjusting for covariates was tested for linearity through the 
fitting of a restricted cubic spline function(28). There is no evidence of significant departure from linearity (P=0.07-0.11). We calculated the 
middle value of each quintile (i.e., 10
th
, 30
th
, 50
th
, 70
th
,90
th
 percentiles) of 24-h urinary sodium excretion in the total population and by BMI 
percentile, and we used the coefficients from the linear regression models to estimate the adjusted mean of the SBP/DBP associated with 
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each of these values by BMI status(29). Similarly, for the SBP/DBP models with potassium or the sodium-potassium ratio, restricted cubic 
splines were also not significant (P=0.25-0.84); thus, we assumed a linear dose-response relationship for all three urinary measurements in 
relation to BP.  
 
We used logistic regression to estimate the adjusted odds ratio (OR) for the associations of 24-h urinary sodium, potassium, and the 
sodium-potassium ratio with hypertension. Again, restricted cubic splines were not significant (P=0.47-0.63), suggesting linear 
dose-response relationships of  24-h urinary sodium, potassium, and the sodium-potassium ratio for prevalence of hypertension. Thus, we 
estimated the ORs comparing the mid-value of each quintile with the lowest quintile (Q5, Q4, Q3, Q2 vs. Q1) while adjusting for covariates.  
 
In both linear and logistic regression, we used 3 models to adjust for covariates. In model 1, we adjusted for age, sex, rural/urban residency, 
and region; in model 2, in addition to the covariates in model 1, we adjusted for educational attainment, smoking status, drinking of alcohol, 
physical activity, and use of antihypertensive medication; in model 3, we further adjusted for BMI as a continuous variable.In models 1–3 
for sodium excretion, we included potassium as a covariate, and for potassium excretion, we included sodium as a covariate.  
 
We tested interactions between urinary sodium and potassium excretion, their ratio, and the broad BMI classification (normal vs. 
overweight/obese) by including the interaction terms in the linear or logistic regression models. We found significant interactions by BMI 
group for the associations between urinary sodium excretion and SBP (P=0.04) and DBP (P=0.03) and a marginally significant interaction 
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for the association of the sodium-potassium ratio and SBP (P=0.07). We found a significant interaction by BMI classification for the 
association between the sodium-potassium ratio and hypertension (P=0.001) but not for sodium (P=0.10) or potassium (P=0.61) alone. 
 
Sensitivity analysis  
We conducted several sensitivity analyses. First, we repeated our analysis by excluding the known hypertensive participants who were 
taking an antihypertensive medication. Awareness of their hypertension status might have changed their intake of sodium(Supplemental 
Table1). Second, we also repeated our analysis by excluding the participants who had self-reported CVD or diabetes (n=71) at baseline 
(Supplemental Table 2). Third, we examined the distribution of 24-h urinary volume and urinary creatinine by the selected characteristics to 
assess the possible effects on the completeness of the urine collection(Supplemental Table3). Fourth, we repeated the analysis using 
alternative measures of incompleteness of urine collection based on excretion of urinary creatinine and other variables and present the results 
in Supplemental Tables4 to 8. Finally, we repeated the analysis by stratifying participants into three groups: normal weight, overweight and 
obese and presented results in Supplemental Tables 9 to 11. 
 
Statistical analyses were performed with SAS 9.3 (SAS Institute Inc.). All tests were 2-sided and a P value<0.05 was considered significant. 
 
Results 
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The mean age of the 1948 participants was 41.4 years (SD=13.9). Out of them, 907 were classified as normal weight, 684 were overweight 
and 357 were obese. More than half of population (53.4%) was overweight or obese, and 22.9% had hypertension. 
 
In the population, the mean 24-h urinary sodium excretionwas235.7 (mmol) (95% confidence interval [CI], 231.6, 239.9), and the mean 
potassium excretion was 40.5 (mmol) (95% CI, 39.6, 41.5). The mean sodium-potassium ratio was 6.8 (95% CI, 6.6, 7.0). Mean 24-h urinary 
sodium and potassium excretion were both significantly higher among overweight/obese adults than among those of normal weight, though 
mean sodium-potassium ratio did not significantly differ (Table 1). 
 
Among all adults, each SD increase in 24-h urinary sodium excretion value (SD=85mmol) was associated with a significant increase of 
1.09mmHg (95% CI, 0.22, 1.96) in SBP after adjusting for age, sex, urban/rural status, region, educational attainment, smoking status, 
drinking, physical activity,use of antihypertensive medication, and urinary excretion of potassium. After additional adjustment for BMI, the 
association between sodium excretion and SBP was not significant (Table 2).  
 
Each rise of 1 SD in potassium excretion (SD=19mmol) was associated with a significantly lower SBP (-0.88 mmHg; 95% CI, -1.58, -0.19) 
when sodium excretion and all the covariates were included in the analysis (Table 2). The association between DBP and 24-h urinary sodium 
excretion was not significant, as was the case for the association of DBP and potassium excretion (Table 3).The sodium-potassium ratio was 
positively and significantly associated with increases in SBP and DBP, with or without adjustment for BMI (Table 2 and Table 3). We 
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observed stronger and more consistent associations between BP and urinary sodium excretion, potassium excretion, and their ratio in the 
overweight/obese population than among those of normal weight (Table 2 and Table 3). 
 
By quintile of urinary sodium, the adjusted SBP increased from 120.9mmHg (95% CI, 119.6, 122.1) in quintile 1 to 121.6mmHg (95% CI, 
119.1, 124.1) in quintile 5 (P=0.313).Among overweight/obese men and women, it increased from 124.1mmHg (95% CI, 122.2, 126.0) in 
quintile 1 to 127.1mmHg (95% CI, 125.2, 128.9) in quintile 5 (P=0.010) (Figure 1). 
 
In a comparison of the highest and the lowest quintiles of sodium excretion, the OR for prevalence of hypertension in the populationas a 
whole, after adjustment for all covariates except for BMI,was 1.62 (95% CI, 1.13, 2.31).After additional adjustment for BMI, it was 1.30 and 
no longer significant (95% CI, 0.91, 1.85). In the same comparison of quintiles, the fully adjusted OR (Model 3) for potassium excretion was 
0.62 (95% CI, 0.42, 0.91), and for the sodium-potassium ratio was 1.54 (95% CI, 1.23, 1.92) (Table 4). The associations of sodium, 
potassium, and the sodium-potassium ratio with hypertension appeared to be stronger in the overweight/obese population than among those 
of normal weight (Table 4). 
 
The pattern of association remained largely unchanged by excluding the participants currently using antihypertension medications or with 
self-reported CVD or diabetes (Supplemental Table 1 and 2). We examined the distribution of urine volume and creatinine by participant 
characteristics and did not find differential levels of incompleteness (Supplemental Table 3). In addition, our results remained largely 
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unchanged in sensitivity analyses conducted on subsets of the study population using 5 different creatinine criteria to exclude participants 
with potentially incomplete urine collections (Supplemental Table 4-8). When analyzing BMI as three groups: i.e. normal, overweight and 
obese, the association between sodium excretion and SBP and prevalence of hypertension were significant among the overweight 
participants, but not among the obese participants. (Supplement Table 9-11).  
 
Discussion 
Using a representative sample of the Shandong adult population aged 18-69 years, we estimateda high average sodium intake (235.7mmol,or 
5400mg/d), a low average intake of potassium (40.5mmol,or 1500mg/d), and a very high sodium-potassium ratio (6.8). Higher sodium 
excretion and the sodium-potassium ratio were associated with higher BP and prevalence of hypertension, and higher potassium excretion 
was inversely associated with BP and hypertension risk, while the observed associations appeared to be stronger in the overweight/obese 
population than in adults of normal weight. 
 
Several earlier studies have examined the association between sodium intake and BP in various Chinese populations(5,17-21,30-33), 
including populations in northern and southern China and multiple ethnics (Supplemental Table 12).The majority of the studies showeda 
positive association between sodium intake and BP(5, 19, 21, 30-33), and the association in some of these reports was attenuated after 
adjusting for covariates,including BMI(5, 21,33).Among these studies, 3 had examined the effect of BMI on the sodium and BP 
relationship(20,21,33). In the multinational INTERSALT and INTERMAP study, no significant interactions were found on the association 
 16 
 
between urinary sodium, potassium intake, and BP by BMI among the Chinese participants (20, 21). In the Yi migration study, a greater 
association between sodium and BP was found among the persons with higher levels of BMI (33). However, in the above 3 studies, the 
samples of Chinese participants were limited (600-900 persons), and prevalence of hypertension and obesity was low. 
 
The role played by body weight in the association between sodium intake and BP remains open to debate (34-36). Two studies suggested 
that obese adolescents had greater BP response/association to sodium intake than did their lean counterparts(15,16). In the TONE study, 
among older obese people with hypertension, there appeared to be an interaction between sodium reduction and weight loss (13). That study 
found that although the combined intervention (weight loss plus reduced sodium intake) was more beneficial than either of the interventions 
alonein reducing BP, the effect of the 2 interventions combined was not purely additive(13). Elsewhere, the GenSalt study suggested that the 
metabolic syndrome, of which obesity is a major component, was associated with differential effects of salt reduction on BP, with the 
number of risk factors for metabolic syndrome increased, the risk of BP changes of high/low sodium dietary intervention increased(14). 
Moreover, an independent association of sodium intake with the risk of cardiovascular disease was found only in the overweight participants 
in the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study (37). 
On the other hand, some studies did not find an effect of BMI on the sodium-BP relationship (20,21,38). In the INTERSALT study, the 
pooled regression coefficients for the effect of sodium intake on BP did not differ between participating centers or individuals in the upper 
(higher) BMI group and those in the lower BMI group(20). It was suggestedin that study controlling for BMI might lead to 
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overadjustment.Because sodium intake was positively associated with BMI, and BMI is better measured than sodium intake, it may 
dominate combined regression models, and thus the greater sodium intake among the higher-BMI participantsmight have contributed to the 
association of BMI with BP. 
 
In our study, BMI was moderately correlated with 24-hr sodium excretion (r=0.15, P<0.001). Adjusting for BMI attenuated the association 
for the population as a whole, which was consistent with the INTERSALT study findings, although we still observed a significant statistical 
interaction on the multiplicative scale of sodium and the sodium-potassium ratio with BP and prevalence of hypertension. Stratified analysis 
by BMI category in our study showed a significant sodium-SBP association among overweight/obese participants but not among those of 
normal weight, suggesting the possible modification of the observed sodium-BP associations by BMI.  
 
Our findings of effect modification by BMI status on the association between sodium intake and BP, if true, might have significant public 
health implications for the prevention and control of hypertension in the Shandong Province and China as a whole. In the last 30 years in 
China, the trends for dietary sodium intake, prevalence of overweight/obesity, and hypertension have changed significantly. In the 1980s, 
while dietary sodium intake was already high, the prevalence of hypertension and overweight/obesity were low (9-10).Although the 
consumption of sodium has decreased slightly over time(7), the prevalence of hypertension and overweight/obesity increased 
dramatically(2,3,10). In China in 2010, of every 10 adults, 3 were hypertensive and 4 were overweight or obese(3,9). Given the rapid 
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increase in the prevalence of overweight and obesity in Shandong Province as well as in China as a whole and the observed effect 
modification by BMI status, the high sodium intake and high sodium-potassium ratio might play an increasingly important role in the 
increased prevalence of hypertension and subsequent risk of CVD. In Shandong Province, the SMASH project, led by the local government 
and agencies from multiple sectors, is taking action to reduce salt intake to 10g/d in 2015 as well as to improve hypertension control(22). 
Our findings in this examination of survey data from SMASH project suggest that sodium reduction should occur alongside interventions to 
reduce obesity such as increasing physical activity and promotion of healthy diets to achieve better hypertension control and consequent 
reduced risk of CVD in Shandong. 
 
A major strength of our study was the collection of timed 24-h urine specimens from representative population samples in Shandong 
Province under strict quality control. Potential limitations also exist. First, having a single 24-h urinesample from the participants might be 
insufficient to account for within- and between-person variation in the usual sodium intake (39,40), variation that might attenuate the 
association with BP (“regression-dilution”) as suggested by other studies(5,18,19).Second,in sensitivity analyses, we used urinary creatinine, 
urine volume, and body weight to assess completeness of urine collection, as we did not have an objective biomarker of completeness such 
as para-aminobenzoic acid (PABA)(41). Our approach might lead to the inclusion of some incomplete urine samples or to the exclusion of 
some complete urine samples and thus introduce an additional source of variability. Third, in our study, covariates were based on self-report 
and thus subject to reporting error. For example, we did not obtain information on the intensity of physical activity or the frequency of 
alcohol consumption. Forth, calorie intake was not available in the SMASH 2011, therefore we couldn’t adjust for the total calorie intake in 
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our analyses. Fifth, we observed insignificant association between 24h sodium and BP among the normal weight participants, but could not 
rule out the potential for reverse causality, when the participants with certain medical conditions who might be less likely to be overweight 
and reduce their sodium intake (42). Furthermore, we observed non-significant association of sodium and BP and prevalence of hypertension 
among obese participants. This non-significant association might be, at least partly, attributed to the limited sample size in the obese group, 
however it deserved further investigation with larger sample size. Finally, SMASH 2011 was a cross-sectional study, and observed 
associations should be interpreted with caution. Follow-up with repeated 24-h urine collection is desirable to evaluate the effects of sodium 
intake on BP and risk of hypertension and possible interactions with BMI. 
 
In our study, the positive association of urinary sodium excretion and the inverse association of potassium excretion with SBP, DBP, and 
prevalence for hypertension were stronger within the overweight/obese participants than among those of normal weight.The 
sodium-potassium ratio was significantly associated with BP and prevalence of hypertension regardless of BMI status and appeared to be a 
stronger predictor for prevalence of hypertension than sodium or potassium alone.The dietary pattern of high sodium and low potassium 
intakes contributes to the high burden of CVD, mainly stroke, in China, and along with the emerging obesity epidemic, represents a major 
threat to public health. It is important to move toward lowered sodium intake and higher potassium intake in the Chinese population to help 
tackle the growing CVD epidemic, which has already affected the health and welfare of millions of people in this country. 
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Legends for Figures 
Figure 1.Systolic blood pressure values by BMI status and 24-h sodium excretion, 24-h potassium excretion, and sodium-potassium ratio 
Data source: Shandong and Ministry of Health Action on Salt and Hypertension (SMASH) project 2011 survey, among adults (n=1948) in 
Shandong Province, China 
BMI: Body mass index. According to the Chinese guidelines for overweight and obesity, overweight is defined as a BMI of 24 to <28. 
Those with a BMI≥28 are considered obese. 
Footnote: We updated Figure footnote as ‘We used 10th, 30th, 50th, 70th and 90th percentiles as the mid-value of each quintile for sodium 
and potassium excretion and sodium-potassium ratio. The value for P10, P30, P50, P70 and P 90 for sodium was 137.0, 188.9, 230.3, 255.4, 
341.3 mmol for all population, 129.9, 178.6, 217.9, 249.5, 312.5 mmol among normal weight population, 144.4, 201.3, 239.8, 257.9 and 
365.4 mmol among overweight/obese population. The value for P10, P30, P50, P70 and P 90 for potassium was 19.7, 29.2, 37.7, 47.6, 65.0 
mmol for all population, 19.2, 28.3, 36.5, 45.5, 61.9 mmol among normal weight population, 20.1, 30.3, 39.0, 49.2 and 68.0 mmol among 
overweight/obese population. The value for P10, P30, P50, P70 and P 90 for sodium-potassium ratio was 3.4, 4.7, 5.8, 7.7, 11.0 for all 
population, 3.3, 4.6, 5.7, 6.4, 10.9 among normal weight population, 3.5, 4.7, 5.9, 7.8, 11.2 among overweight/obese population.’ 
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Table1. The weighted mean of 24-hour sodium excretion, potassium excretion, and sodium-potassium ratio by BMI status 
Characteristic 
All participants (n=1948) Normal weight 
a
(n=907) Overweight/Obese a(n=1041) 
Na (mmol) K (mmol) Na/K Na (mmol) K (mmol) Na/K Na (mmol) K (mmol) Na/K 
All 235.7 40.5 6.8 223.6 38.9 6.7 246.4 42.0 6.9 
Age 
 
     
   <50 years 235.4 40.4 6.8 222 38.7 6.7 247.9 41.9 6.9 
≥ 50 years 236.4 41.0 6.8 227.9 39.4 6.6 243.1 42.2 6.9 
Sex 
 
     
   Male 244.3 39.8 7.1 230 38.7 6.8 257 40.7 7.4 
Female 226.3
b
 41.4 6.5
 b
 216.6
 b
 39.1 6.6 234.8
 b
 43.4
 b
 6.4
 b
 
Hypertension 
 
     
   Yes 245.3 40.1 7.3 223.8 39.1 6.7 243.5 42.5 6.6 
No 232.9
 c
 40.7 6.7
 c
 222.7 37.3 6.7 252.7 41 7.5
 c
 
a.
 According to the Chinese guidelines for overweight and obesity, normal weight is defined as a BMI(kg/m2) of ≥18.5 to <24, while 
overweight is defined as a BMI of 24 to <28. Those with a BMI≥28 are considered obese. 
b.
 Male subjects significantly different than female subjects within total, normal weight and overweight population.
 
c.
 Hypertensive subjects significantly different than non-hypertensive subjects within total, normal weight and overweight population.
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Table2. Adjusted association of sodium excretion, potassium excretion, and sodium-potassium 
ratio with systolic blood pressure by BMI status 
 Na K Na/K 
 β-coefficient 
(95% CI)
a
 p-value  
β-coefficient 
(95% CI)
a
 p-value  
β-coefficient 
(95% CI)
a
 p-value  
All population  
Model 1
b
 1.34 (0.42,2.25) 0.007 -0.96 (-1.75,-0.17) 0.021 0.49 (0.33,0.64) <0.001 
Model 2c 1.09 (0.22,1.96) 0.018 -0.85 (-1.53,-0.16) 0.019 0.43 (0.30,0.57) <0.001 
Model 3
d
 0.46 (-0.33,1.26) 0.231 -0.88 (-1.58,-0.19) 0.016 0.37 (0.26,0.49) <0.001 
Normal weight population 
e
 
Model 1
b
 -0.39 (-1.81,1.03) 0.566 -0.27 (-1.58,1.05) 0.67 0.15 (-0.15,0.44) 0.307 
Model 2
c
 -0.55 (-2.00,0.89) 0.425 -0.09 (-1.27,1.08) 0.865 0.12 (-0.17,0.41) 0.395 
Model 3
d
 -0.66 (-2.01,0.69) 0.313 -0.21 (-1.45,1.02) 0.717 0.12 (-0.18,0.43) 0.403 
Overweight/obese population 
e
 
Model 1b 1.90 (0.85,2.94) 0.002 -1.74 (-2.55,-0.93) <0.001 0.67 (0.42,0.91) <0.001 
Model 2c 1.65 (0.73,2.58) 0.002 -1.60 (-2.39,-0.81) 0.001 0.61 (0.38,0.83) <0.001 
Model 3
d
 1.31 (0.37,2.26) 0.01 -1.43 (-2.23,-0.63) 0.002 0.54 (0.34,0.75) <0.001 
a.
 β-coefficients for the 24hour urine sodium and potassium are presented as per one standard deviation; 
the estimated population standard deviation for 24-hour sodium and 24-hour potassium was 85.0mmol and 
19.0mmol, respectively. P-values for interactions between 24-hour sodium, potassium excretion and BMI 
status were 0.04 and 0.14 for systolic blood pressure and 0.03and 0.49for diastolic blood pressure, 
respectively. 
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b 
Model 1 adjusted for age, sex, urban-rural, and regions. We also included the potassium excretion in the 
regression model for sodium and sodium in the regression model for potassium. 
c 
Model 2 adjusted for all factors in Model 1 plus educational attainment, smoking status, alcohol intake, 
physical activity, and anti-hypertensive medication use.  
d 
Model 3 adjusted for all factors in Model 2 plus BMI as a continuous variable.  
e 
According to the Chinese guidelines for overweight and obesity, normal weight is defined asa BMI(kg/m
2
) 
of ≥18.5 to <24, while overweight is defined as a BMI of 24 to <28. Those with a BMI≥28 are considered 
obese. 
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Table3. Adjusted association of sodium excretion, potassium excretion, and sodium-potassium 
ratio with diastolic blood pressure by BMI status 
 Na K Na/K 
 β-coefficient 
(95% CI)
a
 p-value  
β-coefficient 
(95% CI)
a
 p-value 
β-coefficient 
(95% CI)
a
 p-value  
All 
population 
      
Model 1b 0.89 (0.10,1.67) 0.03 -0.53 (-1.30,0.24) 0.16 0.26 (0.09,0.42) 0.005 
Model 2
c
 0.69 (-0.07,1.44) 0.071 -0.46 (-1.14,0.22) 0.172 0.22 (0.07,0.37) 0.006 
Model 3
d
 0.05 (-0.61,0.71) 0.864 -0.50 (-1.11,0.11) 0.103 0.16 (0.03,0.29) 0.02 
Normal weight population 
e
 
Model 1
b
 -0.39 (-1.55,0.77) 0.478 -0.39 (-1.53,0.74) 0.471 0.07 (-0.20,0.34) 0.598 
Model 2
c
 -0.60 (-1.68,0.49) 0.257 -0.29 (-1.29,0.71) 0.545 0.04 (-0.21,0.29) 0.719 
Model 3
d
 -0.69 (-1.69,0.32) 0.166 -0.39 (-1.42,0.64) 0.428 0.05 (-0.21,0.30) 0.707 
Overweight/obese population
 e 
Model 1b 1.06 (0.36,1.75) 0.006 -0.86 (-1.54,-0.18) 0.017 0.33 (0.17,0.48) <0.001 
Model 2
c
 0.91 (0.27,1.54) 0.008 -0.77 (-1.42,-0.13) 0.022 0.30 (0.15,0.44) 0.001 
Model 3
d
 0.59 (-0.04,1.22) 0.064 -0.62 (-1.26,0.03) 0.062 0.24 (0.10,0.38) 0.002 
a
 β-coefficient for the sodium-potassium ratio is presented as per 1 unit change. P-values for interactions 
between sodium-potassium ratio and BMI status were 0.07 for systolic blood pressure and 0.12for 
diastolic blood pressure, respectively. 
b 
Model 1 adjusted for age, sex, urban-rural, and regions.  
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c 
Model 2 adjusted for all factors in Model 1 plus educational attainment, smoking status, alcohol intake, 
physical activity, and anti-hypertensive medication use.  
d 
Model 3 adjusted for all factors in Model 2 plus BMI as a continuous variable.  
e 
According to the Chinese guidelines for overweight and obesity, normal weight is defined as a BMI(kg/m
2
) 
of ≥18.5 to <24, while overweight is defined as a BMI of 24 to <28. Those with a BMI≥28 are considered 
obese. 
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Table4.Adjusted odds for risk of hypertension, by BMI status and quintile of sodium excretion (mmol), potassium excretion (mmol), 
and sodium-potassium ratio 
 Odds Ratio(95% CI)
a
  
P_trend
b
 
Overall Odds 
Ratio(95% CI)
a
  Q1 Q2  Q3  Q4  Q5 
All population        
Na        
Mid value of quintile/ Range  
137.0 188.9 230.3 255.4 341.3  22.1,750.8 
          Model 1
c
 1.00 1.14(1.05,1.23) 1.26(1.09,1.46) 1.34(1.12,1.62) 1.66(1.21,2.29) 0.001 1.24(1.08,1.41) 
Model 2
d
 1.00 1.13(1.03,1.24) 1.25(1.06,1.47) 1.32(1.08,1.63) 1.62(1.13,2.31) 0.004 1.22(1.05,1.42) 
Model 3
e
 1.00 1.07(0.98,1.17) 1.13(0.96,1.32) 1.16(0.95,1.43) 1.30(0.91,1.85) 0.110 1.11(0.96,1.29) 
K        
Mid value of quintile/ Range 
19.7 29.2 37.7 47.6 65.0  25.4,227.0 
          Model 1
c
 1.00 0.92(0.86,0.99) 0.86(0.75,0.99) 0.79(0.64,0.98) 0.69(0.49,0.97) 0.018 0.85(0.74,0.99) 
Model 2
d
 1.00 0.91(0.85,0.99) 0.84(0.73,0.98) 0.77(0.61,0.97) 0.65(0.45,0.94) 0.013 0.84(0.72,0.98) 
Model 3
e
 1.00 0.90(0.83,0.98) 0.83(0.71,0.96) 0.75(0.59,0.95) 0.62(0.42,0.91) 0.008 0.82(0.70,0.96) 
Na/K        
Mid value of quintile/ Range 3.4 4.7 5.8 7.7 11.0  0.3,37.3 
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 Odds Ratio(95% CI)
a
  
P_trend
b
 
Overall Odds 
Ratio(95% CI)
a
  Q1 Q2  Q3  Q4  Q5 
          Model 1
c
 1.00 1.08(1.04,1.11) 1.15(1.07,1.23) 1.28(1.14,1.45) 1.56(1.26,1.94) <0.001 1.06(1.03,1.09) 
Model 2
d
 1.00 1.08(1.04,1.12) 1.16(1.08,1.24) 1.30(1.15,1.48) 1.61(1.29,2.01) <0.001 1.06(1.03,1.10) 
Model 3
e
 1.00 1.07(1.03,1.11) 1.14(1.07,1.23) 1.27(1.13,1.44) 1.54(1.23,1.92) <0.001 1.06(1.03,1.09) 
Normal weight population
 f
        
Na        
Mid value of quintile/ Range  129.9 178.6 217.9 249.5 312.5  38.9,749.6 
        
          Model 1
c
 
1.00 1.01(0.87,1.17) 1.01(0.77,1.32) 1.01(0.72,1.42) 1.02(0.57,1.83) 0.931 1.01(0.79,1.29) 
Model 2
d
 
1.00 0.96(0.79,1.19) 0.94(0.65,1.36) 0.92(0.58,1.47) 0.87(0.39,1.95) 0.709 0.94(0.67,1.32) 
Model 3
e
 
1.00 0.95(0.78,1.17) 0.92(0.64,1.33) 0.90(0.56,1.43) 0.83(0.37,1.86) 0.623 0.93(0.66,1.29) 
K        
Mid value of quintile/ Range  19.2 28.3 36.5 45.5 61.9  25.1,227.0 
        
          Model 1
c
 
1.00 0.92(0.84,1.01) 0.86(0.72,1.02) 0.79(0.60,1.04) 0.68(0.44,1.06) 0.063 0.85(0.71,1.03) 
Model 2
d
 
1.00 0.93(0.82,1.05) 0.87(0.69,1.09) 0.80(0.56,1.14) 0.70(0.40,1.24) 0.184 0.86(0.68,1.10) 
Model 3
e
 
1.00 0.93(0.82,1.05) 0.86(0.68,1.10) 0.80(0.55,1.15) 0.69(0.38,1.26) 0.186 0.86(0.67,1.10) 
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 Odds Ratio(95% CI)
a
  
P_trend
b
 
Overall Odds 
Ratio(95% CI)
a
  Q1 Q2  Q3  Q4  Q5 
Na/K        
Mid value of quintile/ Range 3.3 4.6 5.7 7.4 10.9  0.7,28.7 
          Model 1
c
 1.00 1.01(0.96,1.05) 1.01(0.93,1.10) 1.02(0.87,1.19) 1.03(0.79,1.36) 0.796 1.00(0.97,1.04) 
Model 2
d
 1.00 1.00(0.93,1.07) 1.00(0.88,1.14) 1.00(0.79,1.27) 1.00(0.66,1.53) 0.992 1.00(0.95,1.06) 
Model 3
e
 1.00 1.00(0.93,1.07) 1.00(0.88,1.14) 1.00(0.79,1.26) 1.00(0.66,1.52) 0.996 1.00(0.95,1.06) 
Overweight/Obese population
 f
 
Na        
Mid value of quintile/ Range  144.4 201.3 239.8 257.9 365.4  22.1,750.8 
        
          Model 1
c
 1.00 1.14(1.03,1.26) 1.26(1.06,1.51) 1.35(1.07,1.69) 1.67(1.13,2.48) 0.005 1.24(1.05,1.46) 
Model 2
d
 1.00 1.15(1.03,1.28) 1.28(1.06,1.55) 1.37(1.08,1.74) 1.72(1.14,2.60) 0.005 1.25(1.06,1.49) 
Model 3
e
 1.00 1.10(0.99,1.23) 1.20(0.99,1.45) 1.26(0.98~ 1.60) 1.48(0.97,2.26) 0.046 1.18(0.99,1.40) 
K        
Mid value of quintile/ Range  20.1 30.3 39.0 49.2 68.0  4.69,155.17 
        
          Model 1
c
 1.00 0.90(0.83,0.98) 0.82(0.70,0.96) 0.74(0.58,0.95) 0.62(0.41,0.91) 0.009 0.82(0.69, 0.96) 
 36 
 
 Odds Ratio(95% CI)
a
  
P_trend
b
 
Overall Odds 
Ratio(95% CI)
a
  Q1 Q2  Q3  Q4  Q5 
Model 2
d
 1.00 0.89(0.81,0.98) 0.80(0.67,0.96) 0.71(0.54,0.94) 0.58(0.37,0.90) 0.008 0.79(0.66,0.96) 
Model 3
e
 1.00 0.90(0.82,0.99) 0.82(0.68,0.98) 0.73(0.56,0.96) 0.60(0.39,0.94) 0.013 0.81(0.67,0.97) 
Na/K        
Mid value of quintile/ Range 3.5 4.7 5.9 7.8 11.2  0.34,37.25 
          Model 1
c
 1.00 1.10(1.05,1.14) 1.19(1.10,1.29) 1.38(1.20,1.59) 1.77(1.37,2.28) <0.001 1.08(1.04,1.12) 
Model 2
d
 1.00 1.10(1.06,1.14) 1.20(1.12,1.29) 1.39(1.22,1.59) 1.81(1.44,2.28) <0.001 1.08(1.05,1.11) 
Model 3
e
 1.00 1.09(1.04,1.13) 1.17(1.08,1.27) 1.33(1.15,1.53) 1.66(1.29,2.14) <0.001 1.07(1.03, 1.11) 
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a 
For urinary sodium and potassium excretion, ORs are for per one standard deviation (SD) increase in 1 
excretion. For sodium-potassium ratio, ORs is per unit change. 2 
b P-value for trend across percentiles of urinary excretion of sodium, potassium or sodium-potassium ratio 3 
based on F-test; all tests were two-tailed. P-values for interactions between 24hour sodium, potassium and 4 
sodium-potassium ration and BMI status on risk for hypertension were 0.10, 0.61, and 0.001 respectively. 5 
c 
Model 1 adjusted for age, sex, urban-rural, and regions.
 
6 
d
Model 2 adjusted for all factors in Model 1 plus educational attainment, smoking status, alcohol intake, 7 
physical activity, and anti-hypertensive medication use. We also included the potassium in the regression 8 
model for sodium and sodium in the regression model for potassium. 9 
eModel 3 adjusted for all factors in Model 2 plus BMI as a continuous variable. 10 
fAccording to the Chinese guidelines for overweight and obesity, normal weight is defined as a BMI(kg/m2) 11 
of ≥18.5 to <24, while overweight is defined as a BMI of 24 to <28. Those with a BMI≥28 are considered 12 
obese. 13 
  14 
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Online Supplemental Material 
Supplemental Table1 Association of urinary sodium, potassium and sodium-potassium ratio with blood 
pressure exclude participants taking anti-hypertensive medications (n=1823 with 877 normal weight 
and 946 overweight/obese) 
 SBP  DBP 
 
β-coefficient 
 (95% CI)
1
 p-value 
 β-coefficient 
 (95% CI)
 1
 p-value  
All population      
Sodium excretion      
Model 1
2
 1.37 (0.48,2.26) 0.01  0.86 (0.10,1.61) 0.03 
Model 2
3
 1.07 (0.15,1.99) 0.03  0.65 (-0.10,1.40) 0.08 
Model 3
4
 0.42 (-0.43,1.26) 0.31  0.01 (-0.66v0.68) 0.98 
Potassium excretion      
Model 1
2
 -0.88 (-1.82,0.06) 0.06  -0.50 (-1.37,0.37) 0.23 
Model 23 -0.76 (-1.61,0.08) 0.07  -0.43 (-1.23,0.37) 0.27 
Model 3
4
 -0.83 (-1.65,-0.01) 0.05  -0.50 (-1.22,0.23) 0.16 
Sodium-potassium ratio      
Model 1
2
 0.44 (0.23,0.65) 0.00  0.26 (0.06,0.45) 0.01 
Model 2
3
 0.39 (0.19,0.59) 0.00  0.22 (0.05,0.40) 0.01 
Model 34 0.33 (0.16,0.50) 0.00  0.16 (0.01,0.31) 0.03 
Normal weight 
population
5
   
 
  
Sodium excretion 
     
Model 12 -0.28 (-1.65,1.09) 0.67  -0.39 (-1.54,0.77) 0.48 
Model 2
3
 -0.62 (-2.06,0.82) 0.37  -0.64 (-1.72,0.44) 0.23 
Model 3
4
 -0.69 (-2.04,0.66) 0.29  -0.70 (-1.71,0.31) 0.16 
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 SBP  DBP 
 
β-coefficient 
 (95% CI)
1
 p-value 
 β-coefficient 
 (95% CI)
 1
 p-value  
Potassium excretion      
Model 1
2
 -0.21 (-1.42,1.01) 0.72  -0.32 (-1.46,0.83) 0.56 
Model 2
3
 -0.06 (-1.17,1.05) 0.90  -0.23 (-1.26,0.80) 0.64 
Model 3
4
 -0.18 (-1.37,1.00) 0.74  -0.33 (-1.39,0.73) 0.52 
Sodium-potassium ratio      
Model 1
2
 0.17 (-0.10,0.44) 0.21  0.07 (-0.20,0.33) 0.60 
Model 23 0.11 (-0.17,0.39) 0.40  0.03 (-0.21,0.28) 0.79 
Model 3
4
 0.12 (-0.17,0.41) 0.40  0.04 (-0.21,0.29) 0.76 
Overweight/obese 
population
5
   
 
  
Sodium excretion      
Model 1
2
 1.92 (0.78,3.05) 0.00  1.03 (0.31,1.76) 0.01 
Model 23 1.68 (0.59,2.77) 0.01  0.91 (0.21,1.61) 0.01 
Model 3
4
 1.31 (0.24,2.39) 0.02  0.57 (-0.13,1.27) 0.10 
Potassium excretion      
Model 1
2
 -1.68 (-2.65,-0.71) 0.00  -0.88 (-1.69,-0.06) 0.04 
Model 2
3
 -1.56 (-2.50,-0.63) 0.00  -0.80 (-1.61,0.00) 0.05 
Model 34 -1.42 (-2.36,-0.48) 0.01  -0.68 (-1.48,0.13) 0.09 
Sodium-potassium ratio      
Model 12 0.60 (0.34,0.86) 0.00  0.35 (0.16,0.54) 0.00 
Model 2
3
 0.56 (0.31,0.82) 0.00  0.33 (0.14,0.51) 0.00 
Model 3
4
 0.50 (0.26,0.73) 0.00  0.27 (0.10,0.44) 0.00 
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1
β-coefficient for the 24hour urine sodium and potassium is presented as per one standard deviation; the 
estimated population standard deviation for 24hour sodium and 24hour potassium was 85.0mmol and 
19.0mmol, respectively. β-coefficient for the sodium-potassium ratio is presented as per 1 unit. 
2
Model 1 adjusted for age, sex, urban-rural, and regions. We also included the potassium in the regression 
model for sodium and sodium in the regression model for potassium in each model. 
3
Model 2 adjusted for all factors in Model 1 plus educational attainment, smoking status, alcohol intake, 
physical activity. We also included the potassium in the regression for sodium and sodium in the 
regression for potassium in each model. 
4
Model 3 adjusted for all factors in Model 2 plus BMI as a continuous variable.  
5
According to the Chinese guidelines for overweight and obesity, normal weight is defined as a 
BMI(kg/m
2
) of ≥18.5 to <24, while overweight is defined as a BMI of 24 to <28. Those with a BMI≥28 
are considered obese. 
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Online Supplemental Material 
Supplemental Table2. Adjusted association of 24hour urinary sodium, potassium and 
sodium-potassium ratio by excluding the participants with self-reported chronic disease (n=1877 with 
888 normal weight and 989 overweight/obese)
1
 
 SBP   DBP 
 
β-coefficient 
 (95% CI)
2
 p-value  
  β-coefficient 
 (95% CI)
2
 p-value  
All population       
Sodium excretion       
Model 1
3
 1.32 (0.40~2.24) 0.008 
  
0.85 (0.07~1.62) 0.035 
Model 2
4
 0.98 (0.09~1.88) 0.034 
  
0.59 (-0.14~1.32) 0.106 
Model 3
5
 0.39 (-0.41~1.19) 0.317 
  
-0.02 (-0.66~0.62) 0.944 
Potassium excretion       
Model 1
3
 -0.85 (-1.67~-0.03) 0.043 
  
-0.49 (-1.34~0.36) 0.239 
Model 24 -0.77 (-1.49~-0.05) 0.038 
  
-0.42 (-1.18~0.34) 0.258 
Model 3
5
 -0.79 (-1.49~-0.08) 0.032 
  
-0.44 (-1.13~0.25) 0.194 
Sodium-potassium 
ratio       
Model 13 0.48 (0.30~0.66) <0.001 
  
0.26 (0.08~0.44) 0.008 
Model 2
4
 0.42 (0.26~0.58) <0.001 
  
0.22 (0.05~0.38) 0.014 
Model 3
5
 0.35 (0.21~0.50) <0.001 
  
0.15 (-0.00~0.30) 0.051 
normal weight 
population
6
       
Sodium excretion 
      
Model 1
3
 -0.44 (-1.88~1.00) 0.522 
  
-0.43 (-1.59~0.74) 0.445 
Model 24 -0.63 (-2.09~0.83) 0.373 
  
-0.64 (-1.71~0.43) 0.219 
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 SBP   DBP 
 
β-coefficient 
 (95% CI)
2
 p-value  
  β-coefficient 
 (95% CI)
2
 p-value  
Model 3
5
 -0.73 (-2.09~0.63) 0.268 
  
-0.73 (-1.72~0.26) 0.138 
Potassium excretion       
Model 1
3
 -0.13 (-1.48~1.22) 0.839 
  
-0.32 (-1.49~0.85) 0.570 
Model 2
4
 0.02 (-1.17~1.22) 0.967 
  
-0.23 (-1.26~0.81) 0.649 
Model 35 -0.09 (-1.35~1.17) 0.879 
  
-0.32 (-1.38~0.74) 0.527 
Sodium-potassium 
ratio       
Model 1
3
 0.13 (-0.17~0.44) 0.366 
  
0.06 (-0.22~0.34) 0.666 
Model 24 0.11 (-0.19~0.41) 0.450 
  
0.03 (-0.23~0.29) 0.797 
Model 3
5
 0.11 (-0.20~0.42) 0.463 
  
0.03 (-0.23~0.29) 0.792 
overweight/obese 
population
6
       
Sodium excretion       
Model 1
3
 1.94 (0.86~3.03) 0.002 
  
1.03 (0.32~1.73) 0.008 
Model 2
4
 1.61 (0.57~2.64) 0.005 
  
0.81 (0.17~1.45) 0.016 
Model 3
5
 1.31 (0.25~2.37) 0.019 
  
0.53 (-0.13~1.19) 0.109 
Potassium excretion       
Model 1
3
 -1.65 (-2.54~-0.75) 0.001 
  
-0.82 (-1.59~-0.06) 0.036 
Model 2
4
 -1.56 (-2.42~-0.69) 0.002 
  
-0.75 (-1.46~-0.04) 0.041 
Model 35 -1.38 (-2.23~-0.53) 0.004 
  
-0.57 (-1.29~0.14) 0.109 
Sodium-potassium 
ratio       
Model 1
3
 0.65 (0.39~0.91) <0.001 
  
0.33 (0.17~0.49) 0.001 
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 SBP   DBP 
 
β-coefficient 
 (95% CI)
2
 p-value  
  β-coefficient 
 (95% CI)
2
 p-value  
Model 2
4
 0.59 (0.35~0.84) <0.001 
  
0.30 (0.14~0.45) 0.001 
Model 3
5
 0.53 (0.31~0.76) <0.001 
  
0.24 (0.08~0.39) 0.006 
1
Among the 1948 participants with complete 24h urine collected, 71 participants were self-reported to 
have chronic disease (34 were self-reported to have diabetes, 14 were stroke, 36 were CHD), leaving 1877 
participants for the sensitive analysis. 
 2
β-coefficient for the 24hour urine sodium and potassium is presented as per one standard deviation; the 
estimated population standard deviation for 24hour sodium and 24hour potassium was 85.0mmol and 
19.0mmol, respectively. β-coefficient for the sodium-potassium ratio is presented as per 1 unit. 
3
Model 1 adjusted for age, sex, urban-rural, and regions. We also included the potassium in the regression 
model for sodium and sodium in the regression model for potassium. 
4
Model 2 adjusted for all factors in Model 1 plus educational attainment, smoking status, alcohol intake, 
physical activity, and anti-hypertensive medication use.  
5
Model 3 adjusted for all factors in Model 2 plus BMI as a continuous variable.  
6
According to the Chinese guidelines for overweight and obesity, normal weight is defined as a BMI(kg/m
2
) 
of ≥18.5 to <24, while overweight is defined as a BMI of 24 to <28. Those with a BMI≥28 are considered 
obese.  
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Online Supplemental Material 
Supplemental Table 3 Distribution of 24-hour urinary volume and urinary creatinine by selected 
demographics, SMASH baseline survey, 2011 
 
24-hour urine volume  24-hour urine creatinine 
N Median (25
th
–75
th
)  Median (25
th
–75
th
) 
Age 
1359 1400 
   
8.8 
  
<50years 1070~1800  6.8~11.2 
≥ 50years 589 1530 1162~2000  7.6 6.1~9.8 
Gender 
1030 1450 
   
10 
  
male 1110~1900  7.3~12.2 
female 918 1420 1070~1820  7.5 6.2~8.9 
City 
619 1500 
   
8.9 
  
urban 1120~1920  6.8~11.3 
rural 1329 1400 1080~1820  8.2 6.5~10.6 
Region 
773 1440 
   
8 
  
south-central 1100~1830  6.3~10.7 
north-west 679 1450 1130~1900  8.2 6.6~10.6 
east 496 1400 1020~1820  9 7.1~11.2 
Education years 
1473 1440 
   
8.2 
  
0-9years 1080~1850  6.5~10.5 
9-12years 297 1390 1055~1870  9 6.9~11.4 
>12years 178 1498 1150~1800  9.6 7~12.4 
Occupation 
947 1420 
   
7.9   6.4~10.3 Farmer or fisherman 1100~1850  
Manufacture worker 285 1350 1040~1900  9.6 6.9~11.7 
Businessman 168 1425 1080~1760  9.1 7~11.3 
Office worker/technicians 183 1510 1190~1980  9.2 6.9~11.8 
Students 
150 1355 
1070~1640  
8.4 
7~11.4 
Houseworker/retired 
212 1545 
   
8.1 
  
/unemployed 1105~1955 6.5~9.8 
Physical activity        
8.2 
  
none 1563 1440 1100~1850  6.5~10.6 
<3times/wk 94 1418 1090~1685  10.2 7.4~12.5 
≥3times/wk 271 1470 1095~1920  9 7~11.5 
BMI status            
normal weight 907 1400 1060~1820  7.9 6.2~10.1 
overweight 684 1450 1105~1850  8.5 6.8~10.9 
obesity 357 1460 1100~1940  9.6 7.3~11.9 
 47 
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Supplemental Table 4 Association of 24hour urinary sodium, potassium and sodium-potassium ratio by 
Reinivuo’s criteria (n=1415 with 604 normal weight and 811 overweight/obese)1 
 SBP  DBP 
 
β-coefficient 
 (95% CI)
2
 p-value  
β-coefficient 
 (95% CI)
2
 p-value  
All population      
Sodium excretion      
Model 1
3
 1.07 (0.21,1.94) 0.01  0.95 (0.38,1.51) 0.00 
Model 2
4
 0.74 (-0.13,1.60) 0.10  0.71 (0.13,1.29) 0.02 
Model 3
5
 -0.06 (-0.91,0.78) 0.88  -0.06 (-0.60,0.47) 0.81 
Potassium excretion      
Model 1
3
 -0.62 (-1.43,0.19) 0.13  -0.48 (-1.02,0.05) 0.07 
Model 2
4
 -0.50 (-1.29,0.29) 0.21  -0.40 (-0.93,0.13) 0.14 
Model 35 -0.57 (-1.33,0.19) 0.14  -0.46 (-0.94,0.02) 0.06 
Sodium-potassium ratio      
Model 13 0.39 (0.12,0.66) 0.00  0.28 (0.10,0.46) 0.00 
Model 2
4
 0.31 (0.05,0.57) 0.02  0.23 (0.05,0.40) 0.01 
Model 3
5
 0.23 (-0.02,0.48) 0.07  0.15 (-0.01,0.31) 0.07 
normal weight population
6
      
Sodium excretion 
     
Model 13 -0.36 (-1.66,0.94) 0.58  -0.18 (-1.02,0.66) 0.67 
Model 2
4
 -0.80 (-2.12,0.51) 0.23  -0.66 (-1.52,0.20) 0.13 
Model 3
5
 -0.91 (-2.22,0.39) 0.17  -0.75 (-1.60,0.09) 0.08 
Potassium excretion      
Model 1
3
 0.03 (-1.15,1.22) 0.95  -0.53 (-1.30,0.24) 0.17 
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 SBP  DBP 
 
β-coefficient 
 (95% CI)2 p-value  
β-coefficient 
 (95% CI)2 p-value  
Model 2
4
 0.23 (-0.94,1.39) 0.70  -0.38 (-1.14,0.38) 0.33 
Model 3
5
 0.12 (-1.03,1.28) 0.83  -0.47 (-1.22,0.27) 0.22 
Sodium-potassium ratio      
Model 1
3
 0.05 (-0.35,0.44) 0.82  0.10 (-0.15,0.36) 0.43 
Model 2
4
 -0.02 (-0.41,0.37) 0.92  0.03 (-0.23,0.28) 0.83 
Model 3
5
 0.01 (-0.38,0.39) 0.98  0.05 (-0.20,0.30) 0.70 
overweight/obese 
population
6
   
 
  
Sodium excretion      
Model 1
3
 1.13 (-0.00,2.26) 0.05  0.83 (0.12,1.55) 0.02 
Model 2
4
 0.90 (-0.25,2.05) 0.12  0.76 (0.02,1.50) 0.04 
Model 3
5
 0.49 (-0.65,1.63) 0.40  0.35 (-0.37,1.07) 0.34 
Potassium excretion      
Model 1
3
 -1.33 (-2.40,-0.26) 0.01  -0.64 (-1.31,0.04) 0.06 
Model 2
4
 -1.23 (-2.28,-0.19) 0.02  -0.61 (-1.28,0.06) 0.08 
Model 3
5
 -1.15 (-2.18,-0.12) 0.03  -0.53 (-1.17,0.12) 0.11 
Sodium-potassium ratio      
Model 1
3
 0.57 (0.22,0.92) 0.00  0.32 (0.10,0.54) 0.01 
Model 2
4
 0.48 (0.13,0.83) 0.01  0.29 (0.06,0.51) 0.01 
Model 35 0.40 (0.06,0.75) 0.02  0.21 (-0.01,0.42) 0.06 
1
 Reinivuo H, Valsta LM, Laatikainen T, Tuomilehto J, Pietinen P.Sodium in the Finnish diet: II trends in 
dietary sodium intake and comparison between intake and 24-h excretion of sodium. Eur J Clin Nutr 2006; 
60: 1160-7. Reinivuo’s criterion to classify incompleteness of 24hour urine collection is urinary creatinine 
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level<6mmol/d plus a total urine volume<1000ml/d. Based on Reinivuo’s criterion, 659 participants in our 
study was classified as incompleteness urine collection and excluded, further 38 participants were 
excluded for low body weight and leaving 1415subject for final analysis. Given the large numbers of 
participants excluded, we didn’t use the weighted means for the association study, and used the sampled 
means for association study. Proc Reg statement was used for the analysis. 
2
β-coefficient for the 24hour urine sodium and potassium is presented as per one standard deviation; the 
estimated population standard deviation for 24hour sodium and 24hour potassium was 85.0mmol and 
19.0mmol, respectively. β-coefficient for the sodium-potassium ratio is presented as per 1 unit. 
3
Model 1 adjusted for age, sex, urban-rural, and regions. We also included the potassium excretion in the 
regression model for sodium and sodium in the regression model for potassium. 
4
Model 2 adjusted for all factors in Model 1 plus educational attainment, smoking status, alcohol intake, 
physical activity, and anti-hypertensive medication use.  
5Model 3 adjusted for all factors in Model 2 plus BMI as a continuous variable. 
6
According to the Chinese guidelines for overweight and obesity, normal weight is defined as a BMI(kg/m
2
) 
of ≥18.5 to <24, while overweight is defined as a BMI of 24 to <28. Those with a BMI≥28 are considered 
obese.  
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Supplemental Table 5 Association of 24hour urinary sodium, potassium and sodium-potassium ratio by 
WHO’s criteria (n=1546 with 717 normal weight and 829 overweight/obese)1 
 SBP  DBP 
 
β-coefficient 
 (95% CI)
2
 p-value 
β-coefficient 
 (95% CI)
2
 p-value  
All population      
Sodium excretion      
Model 1
3
 1.61 (0.77,2.45) 0.00  1.14 (0.60,1.68) 0.00 
Model 2
4
 1.08 (0.23,1.92) 0.01  0.83 (0.27,1.39) 0.00 
Model 3
5
 0.25 (-0.58,1.08) 0.56  -0.02 (-0.54,0.49) 0.94 
Potassium excretion      
Model 1
3
 -0.16 (-1.02,0.71) 0.72  -0.06 (-0.62,0.50) 0.83 
Model 2
4
 -0.06 (-0.89,0.78) 0.89  0.02 (-0.54,0.57) 0.96 
Model 3
5
 -0.43 (-1.24,0.38) 0.30  -0.36 (-0.87,0.14) 0.16 
Sodium-potassium ratio      
Model 1
3
 0.38 (0.11,0.65) 0.01  0.21 (0.03,0.38) 0.02 
Model 2
4
 0.26 (-0.00,0.53) 0.05  0.14 (-0.04,0.31) 0.13 
Model 3
5
 0.24 (-0.02,0.49) 0.07  0.11 (-0.05,0.27) 0.16 
normal weight population
6
      
Sodium excretion 
     
Model 13 0.47 (-0.80,1.74) 0.47  0.07 (-0.72,0.86) 0.86 
Model 2
4
 -0.16 (-1.43,1.11) 0.80  -0.54 (-1.35,0.27) 0.19 
Model 3
5
 -0.22 (-1.49,1.04) 0.73  -0.59 (-1.39,0.20) 0.14 
Potassium excretion      
Model 1
3
 0.20 (-1.08,1.49) 0.75  -0.29 (-1.09,0.51) 0.48 
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 SBP  DBP 
 
β-coefficient 
 (95% CI)
2
 p-value 
β-coefficient 
 (95% CI)
2
 p-value  
Model 2
4
 0.39 (-0.84,1.62) 0.53  -0.14 (-0.92,0.64) 0.72 
Model 3
5
 0.19 (-1.03,1.42) 0.76  -0.31 (-1.08,0.46) 0.43 
Sodium-potassium ratio      
Model 1
3
 0.07 (-0.32,0.45) 0.74  0.00 (-0.24,0.24) 0.99 
Model 24 -0.02 (-0.40,0.36) 0.92  -0.09 (-0.32,0.15) 0.48 
Model 3
5
 0.02 (-0.35,0.40) 0.90  -0.05 (-0.29,0.19) 0.68 
overweight/obese population
6
      
Sodium excretion      
Model 13 1.55 (0.42,2.68) 0.01  0.96 (0.25,1.66) 0.01 
Model 2
4
 1.27 (0.11,2.42) 0.03  0.87 (0.13,1.60) 0.02 
Model 3
5
 0.79 (-0.34,1.93) 0.17  0.42 (-0.28,1.13) 0.24 
Potassium excretion      
Model 1
3
 -1.09 (-2.25,0.06) 0.06  -0.47 (-1.19,0.26) 0.21 
Model 2
4
 -1.00 (-2.13,0.13) 0.08  -0.43 (-1.15,0.28) 0.24 
Model 3
5
 -1.04 (-2.15,0.06) 0.06  -0.48 (-1.16,0.21) 0.17 
Sodium-potassium ratio 
     
Model 1
3
 0.67 (0.29,1.05) 0.00  0.36 (0.13,0.60) 0.00 
Model 2
4
 0.55 (0.18,0.93) 0.00  0.32 (0.08,0.55) 0.01 
Model 35 0.51 (0.14,0.87) 0.01  0.27 (0.05,0.50) 0.02 
1
 WHO Regional Office for Europe. Estimation of sodium intake and output: review of methods and 
recommendations for epidemiological studies. Report on a WHO meeting by the WHO collaborating center 
for research and training in cardiovascular disease.Geneva: World Health Organization. 1984. WHO’s 
criterion to classify incompleteness of 24hour urine collection is ratio of urinary creatinine (mg/d)to body 
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weight (kg) <10.8 or >25.2.Based on WHO’s criterion, 506 participants in our study was classified as 
incompleteness urine collection and excluded, further 50 participants were excluded for low body weight, 
and leaving 1546subject for final analysis. Given the large numbers of participants excluded, we didn’t use 
the weighted means for the association study, and used the sampled means for association study. Proc Reg 
statement was used for the analysis. 
2
β-coefficient for the 24hour urine sodium and potassium is presented as per one standard deviation; the 
estimated population standard deviation for 24hour sodium and 24hour potassium was 85.0mmol and 
19.0mmol, respectively. β-coefficient for the sodium-potassium ratio is presented as per 1 unit. 
3
Model 1 adjusted for age, sex, urban-rural, and regions. We also included the potassium in the regression 
model for sodium and sodium in the regression model for potassium. 
4
Model 2 adjusted for all factors in Model 1 plus educational attainment, smoking status, alcohol intake, 
physical activity, and anti-hypertensive medication use.  
5Model 3 adjusted for all factors in Model 2 plus BMI as a continuous variable.  
6
According to the Chinese guidelines for overweight and obesity, normal weight is defined as a 
BMI(kg/m
2
) of ≥18.5 to <24, while overweight is defined as a BMI of 24 to <28. Those with a BMI≥28 
are considered obese.  
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Supplemental Table 6 Association of 24hour urinary sodium, potassium and sodium-potassium ratio by 
Malekshah’s criteria (n=1289 with 577 normal weight and 712 overweight/obese)1 
 SBP  DBP 
 
β-coefficient 
 (95% CI)
2
 p-value 
 β-coefficient 
 (95% CI)
2
 p-value 
All population      
Sodium excretion      
Model 1
3
 1.84 (0.89,2.79) 0.00  1.36 (0.76,1.95) 0.00 
Model 2
4
 1.32 (0.36,2.28) 0.01  1.10 (0.48,1.72) 0.00 
Model 3
5
 0.41 (-0.54,1.36) 0.39  0.17 (-0.42,0.75) 0.58 
Potassium excretion      
Model 1
3
 -0.26 (-1.26,0.74) 0.61  -0.14 (-0.77,0.49) 0.67 
Model 2
4
 -0.15 (-1.11,0.82) 0.77  -0.07 (-0.69,0.56) 0.83 
Model 35 -0.50 (-1.44,0.44) 0.30  -0.43 (-1.00,0.14) 0.14 
Sodium-potassium ratio      
Model 13 0.48 (0.17,0.78) 0.00  0.27 (0.08,0.46) 0.01 
Model 2
4
 0.35 (0.06,0.65) 0.02  0.20 (0.01,0.39) 0.04 
Model 3
5
 0.30 (0.02,0.59) 0.04  0.15 (-0.03,0.33) 0.09 
normal weight population
6
      
Sodium excretion 
     
Model 13 0.36 (-1.13,1.86) 0.63  0.10 (-0.81,1.01) 0.83 
Model 2
4
 -0.27 (-1.78,1.23) 0.72  -0.50 (-1.43,0.44) 0.30 
Model 3
5
 -0.37 (-1.87,1.13) 0.63  -0.57 (-1.50,0.35) 0.23 
Potassium excretion      
Model 1
3
 0.46 (-1.05,1.98) 0.55  -0.11 (-1.04,0.81) 0.81 
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 SBP  DBP 
 
β-coefficient 
 (95% CI)
2
 p-value 
 β-coefficient 
 (95% CI)
2
 p-value 
Model 2
4
 0.58 (-0.87,2.03) 0.43  -0.01 (-0.91,0.88) 0.97 
Model 3
5
 0.41 (-1.03,1.86) 0.57  -0.15 (-1.04,0.75) 0.75 
Sodium-potassium ratio      
Model 1
3
 0.04 (-0.41,0.50) 0.86  -0.02 (-0.30,0.26) 0.88 
Model 2
4
 -0.02 (-0.46,0.42) 0.92  -0.09 (-0.36,0.18) 0.51 
Model 3
5
 0.00 (-0.43,0.44) 0.98  -0.07 (-0.34,0.20) 0.61 
overweight/obese population
6
      
Sodium excretion      
Model 1
3
 1.91 (0.66,3.16) 0.00  1.24 (0.47,2.01) 0.00 
Model 2
4
 1.72 (0.44,3.01) 0.01  1.22 (0.41,2.03) 0.00 
Model 3
5
 1.22 (-0.05,2.49) 0.06  0.75 (-0.03,1.52) 0.06 
Potassium excretion      
Model 1
3
 -1.43 (-2.74,-0.12) 0.03  -0.78 (-1.58,0.03) 0.06 
Model 2
4
 -1.31 (-2.60,-0.02) 0.05  -0.73 (-1.53,0.08) 0.08 
Model 3
5
 -1.31 (-2.57,-0.05) 0.04  -0.72 (-1.49,0.05) 0.07 
Sodium-potassium ratio      
Model 1
3
 0.76 (0.35,1.17) 0.00  0.43 (0.18,0.68) 0.00 
Model 24 0.66 (0.25,1.06) 0.00  0.39 (0.14,0.65) 0.00 
Model 3
5
 0.60 (0.20,0.99) 0.00  0.34 (0.10,0.58) 0.01 
1 Malekshah AF, Kimiagar M, Saadatian-Elahi M, Pourshams A, Nouraie M, Goglani G, et al.Validity and 
reliability of a new food frequency questionnaire compared to 24 h recalls and biochemical measurements: 
pilot phase of Golestan cohort study of esophageal cancer. Eur J Clin Nutr 2006; 60: 971-7. Malekshal’s 
criterion to classify incompleteness of 24hour urine collection is ratio of urinary creatinine (mg/d)to body 
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weight (kg) <11 or >20.Based on Malekshal’s criterion, 774 participants in our study was classified as 
incompleteness urine collection and excluded, further 49 participants were excluded for low body weight, 
and leaving 1289 subject for final analysis. Given the large numbers of participants excluded, we didn’t 
use the weighted means for the association study, and used the sampled means for association study. 
ProcReg statement was used for the analysis. 
2
β-coefficient for the 24hour urine sodium and potassium is presented as per one standard deviation; the 
estimated population standard deviation for 24hour sodium and 24hour potassium was 85.0mmol and 
19.0mmol, respectively. β-coefficient for the sodium-potassium ratio is presented as per 1 unit. 
3
Model 1 adjusted for age, sex, urban-rural, and regions. We also included the potassium in the regression 
model for sodium and sodium in the regression model for potassium. 
4
Model 2 adjusted for all factors in Model 1 plus educational attainment, smoking status, alcohol intake, 
physical activity, and anti-hypertensive medication use.  
5Model 3 adjusted for all factors in Model 2 plus BMI as a continuous variable.  
6
According to the Chinese guidelines for overweight and obesity, normal weight is defined as a 
BMI(kg/m
2
) of ≥18.5 to <24, while overweight is defined as a BMI of 24 to <28. Those with a BMI≥28 
are considered obese.  
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Supplemental Table 7 Adjusted association of 24hour urinary sodium, potassium and 
sodium-potassium ratio by Joossens and Geboers’s criteria (n=1304 with 659 normal weight and 645 
overweight/obese)1 
 SBP   DBP 
 
β-coefficient 
 (95% CI)
2
 p-value 
  β-coefficient 
 (95% CI)
2
 p-value 
All population       
Sodium excretion       
Model 1
3
 1.28 (0.42,2.13) 0.00   1.07 (0.49,1.65) 0.00 
Model 2
4
 0.86 (-0.01,1.73) 0.05   0.79 (0.20,1.39) 0.01 
Model 35 -0.08 (-0.93,0.77) 0.85   -0.16 (-0.70,0.39) 0.57 
Potassium excretion       
Model 13 -0.28 (-1.12,0.56) 0.51   -0.12 (-0.68,0.45) 0.69 
Model 2
4
 -0.21 (-1.03,0.61) 0.61   -0.06 (-0.61,0.50) 0.84 
Model 3
5
 -0.49 (-1.27,0.30) 0.23   -0.33 (-0.84,0.17) 0.19 
Sodium-potassium ratio       
Model 1
3
 0.26 (-0.03,0.55) 0.08   0.20 (-0.00,0.40) 0.05 
Model 2
4
 0.20 (-0.09,0.48) 0.18   0.15 (-0.05,0.35) 0.14 
Model 3
5
 0.15 (-0.12,0.43) 0.28   0.10 (-0.07,0.28) 0.25 
normal weight 
population
6
   
  
  
Sodium excretion 
      
Model 1
3
 0.29 (-0.99,1.57) 0.65   0.08 (-0.74,0.90) 0.85 
Model 2
4
 -0.23 (-1.51,1.05) 0.72   -0.38 (-1.22,0.45) 0.37 
Model 3
5
 -0.48 (-1.75,0.79) 0.46   -0.60 (-1.41,0.22) 0.15 
Potassium excretion       
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 SBP   DBP 
 
β-coefficient 
 (95% CI)
2
 p-value 
  β-coefficient 
 (95% CI)
2
 p-value 
Model 1
3
 0.05 (-1.17,1.27) 0.94   -0.32 (-1.10,0.46) 0.42 
Model 2
4
 0.28 (-0.89,1.46) 0.63   -0.16 (-0.93,0.60) 0.67 
Model 35 0.14 (-1.03,1.30) 0.82   -0.29 (-1.04,0.46) 0.45 
Sodium-potassium ratio       
Model 13 0.10 (-0.30,0.50) 0.62   0.07 (-0.18,0.33) 0.58 
Model 2
4
 0.02 (-0.37,0.41) 0.93   0.00 (-0.25,0.26) 0.99 
Model 3
5
 0.03 (-0.36,0.41) 0.89   0.01 (-0.24,0.26) 0.94 
overweight/obese 
population
6
   
  
  
Sodium excretion       
Model 13 1.10 (-0.07,2.27) 0.06   0.84 (0.06,1.62) 0.03 
Model 2
4
 0.94 (-0.26,2.14) 0.12   0.75 (-0.05,1.56) 0.07 
Model 3
5
 0.37 (-0.83,1.56) 0.55   0.19 (-0.58,0.97) 0.62 
Potassium excretion       
Model 1
3
 -1.06 (-2.20,0.08) 0.07   -0.35 (-1.10,0.40) 0.36 
Model 24 -1.06 (-2.19,0.06) 0.06   -0.37 (-1.12,0.38) 0.34 
Model 3
5
 -1.10 (-2.21,-0.00) 0.05   -0.41 (-1.12,0.31) 0.26 
Sodium-potassium ratio       
Model 1
3
 0.48 (0.04,0.92) 0.03   0.30 (0.01,0.59) 0.04 
Model 2
4
 0.45 (0.01,0.89) 0.05   0.29 (-0.01,0.58) 0.06 
Model 3
5
 0.39 (-0.05,0.82) 0.08   0.22 (-0.06,0.50) 0.12 
1
 Joossens JV, Geboers J. Monitoring salt intake of the population: methodological 
considerations.Wageningen: Department of Human Nutrition, Agricultural University. 1984. Joossens and 
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Geboers’s criterion to classify incompleteness of 24hour urine collection is gender specific ratio of urinary 
creatinine (mmol/d) to body weight (kg) <0.6.Based on Joossens and Geboers’s criterion, 740 participants 
in our study was classified as incompleteness urine collection and excluded, further 68 participants were 
excluded for low body weight, and leaving 1304 subject for further analysis. Given the large numbers of 
participants excluded, we didn’t use the weighted means for the association study, and used the sampled 
means for association study. Proc reg statement was used for the analysis. 
2
β-coefficient for the 24hour urine sodium and potassium is presented as per one standard deviation; the 
estimated population standard deviation for 24hour sodium and 24hour potassium was 85.0mmol and 
19.0mmol, respectively. β-coefficient for the sodium-potassium ratio is presented as per 1 unit. 
3
Model 1 adjusted for age, sex, urban-rural, and regions. We also included the potassium in the regression 
model for sodium and sodium in the regression model for potassium. 
4
Model 2 adjusted for all factors in Model 1 plus educational attainment, smoking status, alcohol intake, 
physical activity, and anti-hypertensive medication use.  
5
Model 3 adjusted for all factors in Model 2 plus BMI as a continuous variable.  
6
According to the Chinese guidelines for overweight and obesity, normal weight is defined as a BMI(kg/m
2
) 
of ≥18.5 to <24, while overweight is defined as a BMI of 24 to <28. Those with a BMI≥28 are considered 
obese.  
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Supplemental Table 8 Adjusted association of 24hour urinary sodium, potassium and 
sodium-potassium ratio by Knuiman’s criteria (n=917 with 499 normal weight and 418 
overweight/obese)1 
 SBP   DBP 
 
β-coefficient 
 (95% CI)
2
 p-value 
  β-coefficient 
 (95% CI)
2
 p-value 
All population       
Sodium excretion       
Model 1
3
 0.97 (0.03,1.90) 0.04 
  
0.82 (0.16,1.48) 0.01 
Model 2
4
 0.66 (-0.29,1.61) 0.17 
  
0.58 (-0.10,1.25) 0.09 
Model 35 -0.26 (-1.18,0.66) 0.57 
  
-0.36 (-0.98,0.26) 0.26 
Potassium excretion       
Model 13 -0.28 (-1.22,0.66) 0.56 
  
0.09 (-0.57,0.76) 0.78 
Model 2
4
 -0.22 (-1.14,0.71) 0.65 
  
0.15 (-0.51,0.81) 0.65 
Model 3
5
 -0.58 (-1.46,0.31) 0.20 
  
-0.22 (-0.81,0.38) 0.47 
Sodium-potassium 
ratio       
Model 1
3
 0.22 (-0.11,0.54) 0.20 
  
0.14 (-0.09,0.37) 0.25 
Model 2
4
 0.18 (-0.15,0.51) 0.28 
  
0.10 (-0.13,0.33) 0.39 
Model 35 0.17 (-0.14,0.48) 0.28 
  
0.09 (-0.12,0.30) 0.38 
normal weight 
population
6
       
Sodium excretion 
      
Model 13 0.15 (-1.24,1.53) 0.84 
  
-0.09 (-1.01,0.83) 0.85 
Model 2
4
 -0.22 (-1.62,1.19) 0.76 
  
-0.41 (-1.35,0.52) 0.39 
Model 3
5
 -0.42 (-1.81,0.98) 0.56 
  
-0.61 (-1.53,0.31) 0.19 
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 SBP   DBP 
 
β-coefficient 
 (95% CI)
2
 p-value 
  β-coefficient 
 (95% CI)
2
 p-value 
Potassium excretion       
Model 1
3
 -0.43 (-1.81,0.96) 0.55 
  
-0.23 (-1.15,0.69) 0.62 
Model 2
4
 -0.19 (-1.57,1.18) 0.78 
  
-0.09 (-1.01,0.83) 0.84 
Model 3
5
 -0.35 (-1.71,1.02) 0.62 
  
-0.24 (-1.14,0.66) 0.60 
Sodium-potassium 
ratio       
Model 1
3
 0.20 (-0.24,0.65) 0.37 
  
0.09 (-0.20,0.39) 0.55 
Model 2
4
 0.14 (-0.30,0.58) 0.53 
  
0.04 (-0.26,0.33) 0.80 
Model 35 0.16 (-0.28,0.60) 0.47 
  
0.06 (-0.23,0.35) 0.70 
overweight/obese 
population
6
       
Sodium excretion       
Model 1
3
 0.70 (-0.58,1.99) 0.28 
  
0.55 (-0.37,1.46) 0.24 
Model 2
4
 0.51 (-0.82,1.83) 0.45 
  
0.43 (-0.52,1.38) 0.37 
Model 3
5
 -0.27 (-1.57,1.03) 0.68 
  
-0.24 (-1.16,0.67) 0.60 
Potassium excretion       
Model 1
3
 -0.89 (-2.17,0.39) 0.17 
  
-0.14 (-1.05,0.77) 0.77 
Model 2
4
 -0.89 (-2.17,0.38) 0.17 
  
-0.17 (-1.09,0.74) 0.71 
Model 3
5
 -0.97 (-2.20,0.25) 0.12 
  
-0.24 (-1.11,0.62) 0.58 
Sodium-potassium 
ratio       
Model 1
3
 0.39 (-0.13,0.91) 0.14 
  
0.22 (-0.15,0.59) 0.25 
Model 2
4
 0.33 (-0.20,0.86) 0.22 
  
0.20 (-0.18,0.58) 0.31 
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 SBP   DBP 
 
β-coefficient 
 (95% CI)
2
 p-value 
  β-coefficient 
 (95% CI)
2
 p-value 
Model 3
5
 0.26 (-0.25,0.77) 0.32 
  
0.13 (-0.23,0.49) 0.48 
1
 Knuiman JT, Hautvast JG, van der Heyden L, Geboers J, Joossens JV, Tornqvist H, et al.A multi-centre 
study on completeness of urine collection in 11 European centres. I. Some problems with the use of 
creatinine and 4-aminobenzoic acid as markers of the completeness of collection. Hum Nutr Clin Nutr 
1986; 40: 229-37. Knuiman’s criterion to classify incompleteness of 24hour urine collection is gender 
specific ratio of urinary creatinine (mmol/d) to body weight (kg) <0.7.Based on Knuiman’s criterion, 1143 
participants in our study was classified as incompleteness urine collection and excluded, further 52 
participants were excluded for low body weight, and leaving 917 subject for further analysis. Given the 
large numbers of participants excluded, we didn’t use the weighted means for the association study, and 
used the sampled means for association study. Proc reg statement was used for the analysis. 
2
β-coefficient for the 24hour urine sodium and potassium is presented as per one standard deviation; the 
estimated population standard deviation for 24hour sodium and 24hour potassium was 85.0mmol and 
19.0mmol, respectively. β-coefficient for the sodium-potassium ratio is presented as per 1 unit. 
3
Model 1 adjusted for age, sex, urban-rural, and regions. We also included the potassium in the regression 
model for sodium and sodium in the regression model for potassium. 
4
Model 2 adjusted for all factors in Model 1 plus educational attainment, smoking status, alcohol intake, 
physical activity, and anti-hypertensive medication use.  
5
Model 3 adjusted for all factors in Model 2 plus BMI as a continuous variable.  
6
According to the Chinese guidelines for overweight and obesity, normal weight is defined as a BMI(kg/m
2
) 
of ≥18.5 to <24, while overweight is defined as a BMI of 24 to <28. Those with a BMI≥28 are considered 
obese. 
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Online Supplemental Material 
Supplemental Table 9. Adjusted association of sodium excretion, potassium excretion, and 
sodium-potassium ratio with systolic blood pressure by BMI status 
 Na K Na/K 
 β-coefficient 
(95% CI)
a
 p-value  
β-coefficient 
(95% CI)
a
 p-value  
β-coefficient 
(95% CI)
a
 p-value  
All population  
Model 1
b
 1.34 (0.42,2.25) 0.007 -0.96 (-1.75,-0.17) 0.021 0.49 (0.33,0.64) <0.001 
Model 2
c
 1.09 (0.22,1.96) 0.018 -0.85 (-1.53,-0.16) 0.019 0.43 (0.30,0.57) <0.001 
Model 3
d
 0.46 (-0.33,1.26) 0.231 -0.88 (-1.58,-0.19) 0.016 0.37 (0.26,0.49) <0.001 
Normal weight population 
e 
Model 1b -0.39 (-1.81,1.03) 0.566 -0.27 (-1.58,1.05) 0.670 0.15 (-0.15,0.44) 0.307 
Model 2
c
 -0.55 (-2.00,0.89) 0.425 -0.09 (-1.27,1.08) 0.865 0.12 (-0.17,0.41) 0.395 
Model 3
d
 -0.66 (-2.01,0.69) 0.313 -0.21 (-1.45,1.02) 0.717 0.12 (-0.18,0.43) 0.403 
Overweight 
e
 
Model 1
b
 2.47 (0.76,4.17) 0.008 -1.28 (-2.52,-0.04) 0.044 0.57 (0.24,0.89) 0.002 
Model 2
c
 2.05 (0.28,3.81) 0.026 -1.18 (-2.43,0.08) 0.065 0.53 (0.22,0.85) 0.002 
Model 3
d
 2.07 (0.36,3.79) 0.021 -1.28 (-2.50,-0.05) 0.042 0.57 (0.27,0.87) 0.001 
obese       
Model 1b 0.48 (-1.04,2.01) 0.509 -2.66 (-4.19,-1.14) 0.002 0.64 (0.26,1.01) 0.003 
Model 2
c
 0.45 (-0.99,1.89) 0.515 -2.41 (-4.06,-0.76) 0.007 0.59 (0.18,1.00) 0.008 
Model 3
d
 0.43 (-0.98,1.85) 0.524 -2.35 (-4.00,-0.69) 0.009 0.59 (0.17,1.00) 0.009 
a.
 β-coefficients for the 24hour urine sodium and potassium are presented as per one standard deviation; 
the estimated population standard deviation for 24-hour sodium and 24-hour potassium was 85.0mmol and 
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19.0mmol, respectively. P-values for interactions between 24-hour sodium, potassium excretion and BMI 
status were 0.04 and 0.14 for systolic blood pressure and 0.03and 0.49 for diastolic blood pressure, 
respectively. 
b 
Model 1 adjusted for age, sex, urban-rural, and regions. We also included the potassium excretion in the 
regression model for sodium and sodium in the regression model for potassium. 
c 
Model 2 adjusted for all factors in Model 1 plus educational attainment, smoking status, alcohol intake, 
physical activity, and anti-hypertensive medication use.  
d 
Model 3 adjusted for all factors in Model 2 plus BMI as a continuous variable.  
e 
According to the Chinese guidelines for overweight and obesity, normal weight is defined as a BMI(kg/m
2
) 
of ≥18.5 to <24, while overweight is defined as a BMI of 24 to <28. Those with a BMI≥28 are considered 
obese. 
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Supplemental Table 10. Adjusted association of sodium excretion, potassium excretion, and 
sodium-potassium ratio with diastolic blood pressure by BMI status 
 Na K Na/K 
 β-coefficient 
(95% CI)
a
 p-value  
β-coefficient 
(95% CI)
a
 p-value 
β-coefficient 
(95% CI)
a
 p-value  
All 
population 
      
Model 1b 0.89 (0.10,1.67) 0.03 -0.53 (-1.30,0.24) 0.16 0.26 (0.09,0.42) 0.005 
Model 2
c
 0.69 (-0.07,1.44) 0.071 -0.46 (-1.14,0.22) 0.172 0.22 (0.07,0.37) 0.006 
Model 3
d
 0.05 (-0.61,0.71) 0.864 -0.50 (-1.11,0.11) 0.103 0.16 (0.03,0.29) 0.02 
Normal weight population 
e
 
Model 1
b
 -0.39 (-1.55,0.77) 0.478 -0.39 (-1.53,0.74) 0.471 0.07 (-0.20,0.34) 0.598 
Model 2
c
 -0.60 (-1.68,0.49) 0.257 -0.29 (-1.29,0.71) 0.545 0.04 (-0.21,0.29) 0.719 
Model 3
d
 -0.69 (-1.69,0.32) 0.166 -0.39 (-1.42,0.64) 0.428 0.05 (-0.21,0.30) 0.707 
Overweight
 e
 
Model 1b 0.82 (-0.10,1.73) 0.075 -0.47 (-1.37,0.43) 0.279 0.27 (0.06,0.47) 0.014 
Model 2
c
 0.58 (-0.40,1.57) 0.224 -0.41 (-1.31,0.49) 0.348 0.25 (0.05,0.45) 0.020 
Model 3
d
 0.61 (-0.27,1.49) 0.161 -0.50 (-1.33,0.33) 0.219 0.28 (0.10,0.46) 0.005 
Obese       
Model 1
b
 0.72 (-0.04,1.48) 0.063 -1.32 (-2.28,-0.36) 0.011 0.27 (-0.02,0.56) 0.065 
Model 2
c
 0.61 (-0.14,1.37) 0.102 -1.20 (-2.19,-0.21) 0.021 0.25 (-0.06,0.57) 0.108 
Model 3
d
 0.59 (-0.21,1.38) 0.138 -1.10 (-2.15,-0.05) 0.041 0.25 (-0.07,0.57) 0.119 
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a
 β-coefficient for the sodium-potassium ratio is presented as per 1 unit change. P-values for interactions 
between sodium-potassium ratio and BMI status were 0.07 for systolic blood pressure and 0.12for 
diastolic blood pressure, respectively. 
b 
Model 1 adjusted for age, sex, urban-rural, and regions.  
c 
Model 2 adjusted for all factors in Model 1 plus educational attainment, smoking status, alcohol intake, 
physical activity, and anti-hypertensive medication use.  
d 
Model 3 adjusted for all factors in Model 2 plus BMI as a continuous variable.  
e 
According to the Chinese guidelines for overweight and obesity, normal weight is defined as a BMI(kg/m
2
) 
of ≥18.5 to <24, while overweight is defined as a BMI of 24 to <28. Those with a BMI≥28 are considered 
obese. 
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Supplemental Table 11.Adjusted odds for risk of hypertension, by BMI status and quintile of sodium excretion, potassium excretion, and 
sodium-potassium ratio 
 Odds Ratio(95% CI)
a
  
P_trend
b
 
Overall Odds 
Ratio(95% CI)
a
  Q1 Q2  Q3  Q4  Q5 
All population        
Na        
       Model 1
c
 1.00 1.14(1.05,1.23) 1.26(1.09,1.46) 1.34(1.12,1.62) 1.66(1.21,2.29) 0.001 1.24(1.08,1.41) 
Model 2
d
 1.00 1.13(1.03,1.24) 1.25(1.06,1.47) 1.32(1.08,1.63) 1.62(1.13,2.31) 0.004 1.22(1.05,1.42) 
Model 3
e
 1.00 1.07(0.98,1.17) 1.13(0.96,1.32) 1.16(0.95,1.43) 1.30(0.91,1.85) 0.110 1.11(0.96,1.29) 
K        
       Model 1
c
 1.00 0.92(0.86,0.99) 0.86(0.75,0.99) 0.79(0.64,0.98) 0.69(0.49,0.97) 0.018 0.85(0.74,0.99) 
Model 2
d
 1.00 0.91(0.85,0.99) 0.84(0.73,0.98) 0.77(0.61,0.97) 0.65(0.45,0.94) 0.013 0.84(0.72,0.98) 
Model 3
e
 1.00 0.90(0.83,0.98) 0.83(0.71,0.96) 0.75(0.59,0.95) 0.62(0.42,0.91) 0.008 0.82(0.70,0.96) 
Na/K        
       Model 1
c
 1.00 1.08(1.04,1.11) 1.15(1.07,1.23) 1.28(1.14,1.45) 1.56(1.26,1.94) <0.001 1.06(1.03,1.09) 
Model 2
d
 1.00 1.08(1.04,1.12) 1.16(1.08,1.24) 1.30(1.15,1.48) 1.61(1.29,2.01) <0.001 1.06(1.03,1.10) 
Model 3
e
 1.00 1.07(1.03,1.11) 1.14(1.07,1.23) 1.27(1.13,1.44) 1.54(1.23,1.92) <0.001 1.06(1.03,1.09) 
Normal weight population
 f
        
Na        
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 Odds Ratio(95% CI)
a
  
P_trend
b
 
Overall Odds 
Ratio(95% CI)
a
  Q1 Q2  Q3  Q4  Q5 
       Model 1
c
 
1.00 1.01(0.87,1.17) 1.01(0.77,1.32) 1.01(0.72,1.42) 1.02(0.57,1.83) 0.931 1.01(0.79,1.29) 
Model 2
d
 
1.00 0.96(0.79,1.19) 0.94(0.65,1.36) 0.92(0.58,1.47) 0.87(0.39,1.95) 0.709 0.94(0.67,1.32) 
Model 3
e
 
1.00 0.95(0.78,1.17) 0.92(0.64,1.33) 0.90(0.56,1.43) 0.83(0.37,1.86) 0.623 0.93(0.66,1.29) 
K        
       Model 1
c
 
1.00 0.92(0.84,1.01) 0.86(0.72,1.02) 0.79(0.60,1.04) 0.68(0.44,1.06) 0.063 0.85(0.71,1.03) 
Model 2
d
 
1.00 0.93(0.82,1.05) 0.87(0.69,1.09) 0.80(0.56,1.14) 0.70(0.40,1.24) 0.184 0.86(0.68,1.10) 
Model 3
e
 
1.00 0.93(0.82,1.05) 0.86(0.68,1.10) 0.80(0.55,1.15) 0.69(0.38,1.26) 0.186 0.86(0.67,1.10) 
Na/K        
       Model 1
c
 1.00 1.01(0.96,1.05) 1.01(0.93,1.10) 1.02(0.87,1.19) 1.03(0.79,1.36) 0.796 1.00(0.97,1.04) 
Model 2
d
 1.00 1.00(0.93,1.07) 1.00(0.88,1.14) 1.00(0.79,1.27) 1.00(0.66,1.53) 0.992 1.00(0.95,1.06) 
Model 3
e
 1.00 1.00(0.93,1.07) 1.00(0.88,1.14) 1.00(0.79,1.26) 1.00(0.66,1.52) 0.996 1.00(0.95,1.06) 
Overweight
 f
 
Na        
       Model 1
c
 1.00 1.25( 1.10, 1.42) 1.50( 1.20, 1.89) 1.68( 1.25, 2.24) 2.44( 1.48, 4.02) <0.001 1.45( 1.18, 1.78) 
Model 2
d
 1.00 1.25( 1.07, 1.45) 1.49( 1.14, 1.95) 1.66( 1.18, 2.33) 2.39( 1.32, 4.32) 0.002 1.44( 1.12, 1.84) 
Model 3
e
 1.00 1.27( 1.09, 1.46) 1.53( 1.17, 1.98) 1.71( 1.23, 2.38) 2.52( 1.42, 4.48) 0.001 1.47( 1.16, 1.87) 
K        
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 Odds Ratio(95% CI)
a
  
P_trend
b
 
Overall Odds 
Ratio(95% CI)
a
  Q1 Q2  Q3  Q4  Q5 
       Model 1
c
 1.00 0.89( 0.78, 1.00) 0.80( 0.63, 1.01) 0.70( 0.49, 1.01) 0.56( 0.31, 1.02) 0.039 0.79( 0.61, 1.01) 
Model 2
d
 1.00 0.87( 0.74, 1.02) 0.77( 0.57, 1.04) 0.66( 0.42, 1.06) 0.51( 0.24, 1.09) 0.059 0.76( 0.55, 1.04) 
Model 3
e
 1.00 0.85( 0.71, 1.00) 0.73( 0.53, 1.00) 0.61( 0.37, 1.00) 0.45( 0.20, 1.01) 0.034 0.71( 0.51, 1.00) 
Na/K        
       Model 1
c
 1.00 1.13( 1.06, 1.21) 1.26( 1.11, 1.44) 1.52( 1.21, 1.92) 2.12( 1.40, 3.21) <0.001 1.10( 1.05, 1.17) 
Model 2
d
 1.00 1.14( 1.06, 1.23) 1.29( 1.12, 1.49) 1.59( 1.23, 2.05) 2.29( 1.45, 3.59) <0.001 1.12( 1.05, 1.18) 
Model 3
e
 1.00 1.17( 1.08, 1.26) 1.35( 1.16, 1.57) 1.71( 1.30, 2.25) 2.60( 1.59, 4.25) <0.001 1.13( 1.06, 1.21) 
Obese
 f
 
       
Na  
       Model 1
c
 1.00 0.97( 0.85, 1.10) 0.95( 0.75, 1.19) 0.93( 0.70, 1.25) 0.89( 0.54, 1.47) 0.607 0.95( 0.77, 1.17) 
Model 2
d
 1.00 1.00( 0.87, 1.14) 1.00( 0.79, 1.26) 1.00( 0.74, 1.34) 0.99( 0.59, 1.66) 0.973 1.00( 0.80, 1.24) 
Model 3
e
 1.00 1.00( 0.87, 1.14) 0.99( 0.78, 1.26) 0.99( 0.73, 1.35) 0.99( 0.58, 1.67) 0.959 0.99( 0.80, 1.24) 
K  
       Model 1
c
 1.00 0.91( 0.82, 1.01) 0.84( 0.68, 1.03) 0.76( 0.55, 1.04) 0.64( 0.38, 1.07) 0.062 0.83( 0.67, 1.03) 
Model 2
d
 1.00 0.90( 0.79, 1.03) 0.83( 0.64, 1.06) 0.74( 0.50, 1.10) 0.62( 0.33, 1.17) 0.107 0.82( 0.63, 1.07) 
Model 3
e
 1.00 0.91( 0.79, 1.04) 0.83( 0.64, 1.08) 0.75( 0.50, 1.13) 0.63( 0.32, 1.22) 0.131 0.82( 0.62, 1.09) 
Na/K  
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 Odds Ratio(95% CI)
a
  
P_trend
b
 
Overall Odds 
Ratio(95% CI)
a
  Q1 Q2  Q3  Q4  Q5 
       Model 1
c
 1.00 1.03( 0.95, 1.12) 1.07( 0.91, 1.25) 1.12( 0.84, 1.50) 1.23( 0.74, 2.06) 0.379 1.03( 0.96, 1.10) 
Model 2
d
 1.00 1.04( 0.95, 1.14) 1.09( 0.91, 1.30) 1.16( 0.84, 1.60) 1.31( 0.74, 2.31) 0.313 1.04( 0.96, 1.12) 
Model 3
e
 1.00 1.05( 0.95, 1.15) 1.09( 0.91, 1.30) 1.17( 0.84, 1.61) 1.32( 0.74, 2.35) 0.306 1.04( 0.96, 1.12) 
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a 
For urinary sodium and potassium excretion, ORs are for per one standard deviation (SD) increase 
in excretion. For sodium-potassium ratio, ORs is per unit change. 
b 
P-value for trend across percentiles of urinary excretion of sodium, potassium or 
sodium-potassium ratio based on F-test; all tests were two-tailed. P-values for interactions between 
24hour sodium, potassium and sodium-potassium ration and BMI status on risk for hypertension 
were 0.10, 0.61, and 0.001 respectively. 
c Model 1 adjusted for age, sex, urban-rural, and regions. 
d
Model 2 adjusted for all factors in Model 1 plus educational attainment, smoking status, alcohol 
intake, physical activity, and anti-hypertensive medication use. We also included the potassium in 
the regression model for sodium and sodium in the regression model for potassium. 
e
Model 3 adjusted for all factors in Model 2 plus BMI as a continuous variable. 
f
According to the Chinese guidelines for overweight and obesity, normal weight is defined as a 
BMI(kg/m2) of ≥18.5 to <24, while overweight is defined as a BMI of 24 to <28. Those with a 
BMI≥28 are considered obese. 
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Supplemental Table 12. The observational studies on the association between sodium intake and 
blood pressure in Chinese population (from urine collection samples) 
Study N 
Urine 
samples 
collected 
Sodium-BP 
association 
Is BMI 
adjusted?  
Regression 
coefficient 
sodium and SBP 
(mmHg/1 
mmol) 
INTERSALT 
Chinese, 1988 (5) 600 24h urine positive Yes 0.03-0.08 
Kesteloot et al, 
1987 (30) 2008 24h urine positive No 0.028-0.039 
He et al,1991 (31) 419 24h urine positive Yes 0.02 
Tian et al, 1995 
(19) 663 24h urine positive Yes 0.03 
Liu et al, 2000 (32) 619 24h urine positive Yes 0.038 
Zhao et al, 2004 
(21) 839 24h urine positive Yes 
Without 
BMI:0.024 
With BMI:0.016 
1
The value was the product of regression coefficient and deviation of urinary sodium (25mmol/l). 
 
 
